Jerome B. Zeldis
65Patents
20h-index
19Co-inventors
85Inventor score
Filing activity: Dec 6, 1988 → May 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9101621B2 | Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation | Emerging Cross-Sectional Technologies | 710 | Active |
| US7189740B2 | Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes | Human Necessities | 94 | Expired |
| US7968569B2 | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione | Emerging Cross-Sectional Technologies | 73 | Expired |
| US7393862B2 | Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias | Chemistry; Metallurgy | 66 | Expired |
| US8198262B2 | Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione | Emerging Cross-Sectional Technologies | 59 | Active |
| US7468363B2 | Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione | Emerging Cross-Sectional Technologies | 52 | Expired |
| US8198306B2 | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor | Emerging Cross-Sectional Technologies | 49 | Active |
| US7863297B2 | Methods of using 4-(amino)-2-(2,6-dioxo(3-piperidly))-isoindoline-3-dione for the treatment of myelodysplastic syndromes | Human Necessities | 36 | Active |
| US6255325A | Chronic, bolus administration of D-threo methylphenidate | Chemistry; Metallurgy | 33 | Expired |
| US8188118B2 | Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies | Emerging Cross-Sectional Technologies | 31 | Active |
| US7323479B2 | Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline | Human Necessities | 29 | Expired |
| US9101622B2 | Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone | Emerging Cross-Sectional Technologies | 28 | Active |
| US8648095B2 | Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor | Emerging Cross-Sectional Technologies | 27 | Active |
| US8673939B2 | Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione | Emerging Cross-Sectional Technologies | 27 | Active |
| US8530498B1 | Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione | Emerging Cross-Sectional Technologies | 26 | Active |
| US5984887A | Photopheresis treatment of leukocytes | Human Necessities | 26 | Expired |
| US7115631B2 | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate | Chemistry; Metallurgy | 26 | Expired |
| US8207200B2 | Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation | Emerging Cross-Sectional Technologies | 25 | Active |
| US8735428B2 | Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione | Emerging Cross-Sectional Technologies | 24 | Active |
| US7393863B2 | Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl-carboxamide for the treatment and management of myelodysplastic syndromes | Human Necessities | 24 | Active |
| US8759375B2 | Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor | Emerging Cross-Sectional Technologies | 18 | Active |
| US6602887B2 | Chronic, bolus administration of D-threo methylphenidate | Chemistry; Metallurgy | 16 | Expired |
| US5985914A | Treatment of inflammatory disorders of the bowel and urinary bladder | Human Necessities | 15 | Expired |
| US8722647B2 | Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dione | Emerging Cross-Sectional Technologies | 14 | Active |
| US7563810B2 | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases | Human Necessities | 13 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.